Statements (58)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Mumps
|
| gptkbp:caused_by |
mumps
|
| gptkbp:complications |
gptkb:psychologist
meningitis deafness orchitis oophoritis |
| gptkbp:family |
gptkb:Paramyxoviridae
|
| gptkbp:genus |
gptkb:Morbillivirus
|
| gptkbp:grooming_needs |
saliva
urine nasopharyngeal secretions |
| gptkbp:healthcare |
vaccine recommendations
|
| gptkbp:historical_event |
first vaccine developed in 1967
|
| gptkbp:hosts |
gptkb:Person
|
| https://www.w3.org/2000/01/rdf-schema#label |
mumps virus
|
| gptkbp:incubation_period |
16 to 18 days
|
| gptkbp:instrument |
PCR testing
virus isolation Ig M antibody detection |
| gptkbp:is_a_route_for |
respiratory tract
|
| gptkbp:is_monitored_by |
monitoring of cases
|
| gptkbp:is_protected_by |
gptkb:MMR_vaccine
|
| gptkbp:is_recognized_by |
1934
|
| gptkbp:is_vulnerable_to |
live attenuated vaccine
two doses recommended approximately 88% after two doses administered in childhood |
| gptkbp:public_awareness |
importance of vaccination
|
| gptkbp:research |
studies on viral pathogenesis
ongoing studies on vaccine efficacy investigations into long-term immunity |
| gptkbp:risk_factor |
travel to endemic areas
lack of vaccination close contact with infected individuals |
| gptkbp:seed_dispersal |
single-stranded RNA
|
| gptkbp:social_responsibility |
clinical evaluation
global distribution serological tests vaccination campaigns pancreatitis viral meningitis myocarditis common in unvaccinated populations |
| gptkbp:social_structure |
enveloped virus
|
| gptkbp:symptoms |
fatigue
headache muscle pain fever loss of appetite swelling of salivary glands |
| gptkbp:transmission |
airborne droplets
|
| gptkbp:treatment |
hydration
rest pain relief supportive care |